Ledger.Open graph →
SEC Form D · filed December 23, 2019

Kinnate Biopharma Inc

Offering
$74.5M
Sold
$74.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Stephen W. Kaldor · San Diego, CAExec · Director · PromoterCarl W. Gordon · San Diego, CADirectorMichael W. Rome · San Diego, CADirectorEric W. Murphy · San Diego, CAExec · DirectorBret W. Zbar · San Diego, CADirectorStephen W. Kaldor · La Jolla, CAExec · Director · PromoterEric W. Murphy · San Diego, CAExec · DirectorBret W. Zbar · San Diego, CADirectorCarl W. Gordon · San Diego, CADirectorMichael W. Rome · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗